ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diabetes Software Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-9F2714
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Diabetes Software Market Insights Forecast to 2028
BUY CHAPTERS

Global Diabetes Software Market Insights, Forecast to 2030

Code: QYRE-Auto-9F2714
Report
December 2024
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
Bionime
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health

Diabetes Software Market

Diabetes software can include aggregate and analytical views of diabetes data. These views include:
– Calendar views that display glucose trends and compare them to patient’s insulin intake.
– Modal day views that display glucose trends and compare them to insulin intake on the same day of the week over time.
– Listing of contextual and lifestyle data such as patient’s carb intake.
– Insulin data that includes pie charts showing the ratio of basal to bolus rates.
– General data tables that show average blood glucose rates bucketed into different time periods
– And more.
More advanced diabetes software applications can include predictive insights. These insights can provide patients with alerts regarding their propensity to experience hyperglycemia or hypoglycemia events under certain conditions.
Market Analysis and Insights: Global Diabetes Software Market
The global Diabetes Software market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Covers:
This report presents an overview of global market for Diabetes Software market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Diabetes Software, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Diabetes Software, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Diabetes Software revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Diabetes Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Diabetes Software revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Diabetes Software Market Report

Report Metric Details
Report Name Diabetes Software Market
Segment by Type
  • For Smartphones
  • For Tablet PC
  • Web-based
Segment by Application
  • Type 1 Diabetes
  • Type 2 Diabetes
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Glooko, Accu-Chek (Roche), Tidepool, LifeScan, Inc (Platinum Equity), Pharmaco Diabetes, Ascensia Diabetes Care Holdings AG, Diabeto Medtech India Pvt. Ltd, Abbott Diabetes Care, Acon Diabetes Care International, BIONIME, Custo med, Dexcom, Dottli, GlucoMe, MyLife, Nova, Tandem Diabetes Care, Trividia Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Diabetes Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Diabetes Software companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetes Software revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Diabetes Software Market report?

Ans: The main players in the Diabetes Software Market are Glooko, Accu-Chek (Roche), Tidepool, LifeScan, Inc (Platinum Equity), Pharmaco Diabetes, Ascensia Diabetes Care Holdings AG, Diabeto Medtech India Pvt. Ltd, Abbott Diabetes Care, Acon Diabetes Care International, BIONIME, Custo med, Dexcom, Dottli, GlucoMe, MyLife, Nova, Tandem Diabetes Care, Trividia Health

What are the Application segmentation covered in the Diabetes Software Market report?

Ans: The Applications covered in the Diabetes Software Market report are Type 1 Diabetes, Type 2 Diabetes

What are the Type segmentation covered in the Diabetes Software Market report?

Ans: The Types covered in the Diabetes Software Market report are For Smartphones, For Tablet PC, Web-based

Recommended Reports

Diabetes Management Devices

Diabetes Therapy Drugs

Healthcare Software Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Software Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 For Smartphones
1.2.3 For Tablet PC
1.2.4 Web-based
1.3 Market by Application
1.3.1 Global Diabetes Software Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Software Market Perspective (2019-2030)
2.2 Global Diabetes Software Growth Trends by Region
2.2.1 Diabetes Software Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diabetes Software Historic Market Size by Region (2019-2024)
2.2.3 Diabetes Software Forecasted Market Size by Region (2025-2030)
2.3 Diabetes Software Market Dynamics
2.3.1 Diabetes Software Industry Trends
2.3.2 Diabetes Software Market Drivers
2.3.3 Diabetes Software Market Challenges
2.3.4 Diabetes Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Diabetes Software by Players
3.1.1 Global Diabetes Software Revenue by Players (2019-2024)
3.1.2 Global Diabetes Software Revenue Market Share by Players (2019-2024)
3.2 Global Diabetes Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Diabetes Software, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Diabetes Software Market Concentration Ratio
3.4.1 Global Diabetes Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Software Revenue in 2023
3.5 Global Key Players of Diabetes Software Head office and Area Served
3.6 Global Key Players of Diabetes Software, Product and Application
3.7 Global Key Players of Diabetes Software, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Software Breakdown Data by Type
4.1 Global Diabetes Software Historic Market Size by Type (2019-2024)
4.2 Global Diabetes Software Forecasted Market Size by Type (2025-2030)
5 Diabetes Software Breakdown Data by Application
5.1 Global Diabetes Software Historic Market Size by Application (2019-2024)
5.2 Global Diabetes Software Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diabetes Software Market Size (2019-2030)
6.2 North America Diabetes Software Market Size by Type
6.2.1 North America Diabetes Software Market Size by Type (2019-2024)
6.2.2 North America Diabetes Software Market Size by Type (2025-2030)
6.2.3 North America Diabetes Software Market Share by Type (2019-2030)
6.3 North America Diabetes Software Market Size by Application
6.3.1 North America Diabetes Software Market Size by Application (2019-2024)
6.3.2 North America Diabetes Software Market Size by Application (2025-2030)
6.3.3 North America Diabetes Software Market Share by Application (2019-2030)
6.4 North America Diabetes Software Market Size by Country
6.4.1 North America Diabetes Software Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Diabetes Software Market Size by Country (2019-2024)
6.4.3 North America Diabetes Software Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Diabetes Software Market Size (2019-2030)
7.2 Europe Diabetes Software Market Size by Type
7.2.1 Europe Diabetes Software Market Size by Type (2019-2024)
7.2.2 Europe Diabetes Software Market Size by Type (2025-2030)
7.2.3 Europe Diabetes Software Market Share by Type (2019-2030)
7.3 Europe Diabetes Software Market Size by Application
7.3.1 Europe Diabetes Software Market Size by Application (2019-2024)
7.3.2 Europe Diabetes Software Market Size by Application (2025-2030)
7.3.3 Europe Diabetes Software Market Share by Application (2019-2030)
7.4 Europe Diabetes Software Market Size by Country
7.4.1 Europe Diabetes Software Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Diabetes Software Market Size by Country (2019-2024)
7.4.3 Europe Diabetes Software Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Diabetes Software Market Size (2019-2030)
8.2 China Diabetes Software Market Size by Type
8.2.1 China Diabetes Software Market Size by Type (2019-2024)
8.2.2 China Diabetes Software Market Size by Type (2025-2030)
8.2.3 China Diabetes Software Market Share by Type (2019-2030)
8.3 China Diabetes Software Market Size by Application
8.3.1 China Diabetes Software Market Size by Application (2019-2024)
8.3.2 China Diabetes Software Market Size by Application (2025-2030)
8.3.3 China Diabetes Software Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Diabetes Software Market Size (2019-2030)
9.2 Asia Diabetes Software Market Size by Type
9.2.1 Asia Diabetes Software Market Size by Type (2019-2024)
9.2.2 Asia Diabetes Software Market Size by Type (2025-2030)
9.2.3 Asia Diabetes Software Market Share by Type (2019-2030)
9.3 Asia Diabetes Software Market Size by Application
9.3.1 Asia Diabetes Software Market Size by Application (2019-2024)
9.3.2 Asia Diabetes Software Market Size by Application (2025-2030)
9.3.3 Asia Diabetes Software Market Share by Application (2019-2030)
9.4 Asia Diabetes Software Market Size by Region
9.4.1 Asia Diabetes Software Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Diabetes Software Market Size by Region (2019-2024)
9.4.3 Asia Diabetes Software Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Diabetes Software Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Diabetes Software Market Size by Type
10.2.1 Middle East, Africa, and Latin America Diabetes Software Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Diabetes Software Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Diabetes Software Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Diabetes Software Market Size by Application
10.3.1 Middle East, Africa, and Latin America Diabetes Software Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Diabetes Software Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Diabetes Software Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Diabetes Software Market Size by Country
10.4.1 Middle East, Africa, and Latin America Diabetes Software Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Diabetes Software Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Diabetes Software Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Glooko
11.1.1 Glooko Company Details
11.1.2 Glooko Business Overview
11.1.3 Glooko Diabetes Software Introduction
11.1.4 Glooko Revenue in Diabetes Software Business (2019-2024)
11.1.5 Glooko Recent Developments
11.2 Accu-Chek (Roche)
11.2.1 Accu-Chek (Roche) Company Details
11.2.2 Accu-Chek (Roche) Business Overview
11.2.3 Accu-Chek (Roche) Diabetes Software Introduction
11.2.4 Accu-Chek (Roche) Revenue in Diabetes Software Business (2019-2024)
11.2.5 Accu-Chek (Roche) Recent Developments
11.3 Tidepool
11.3.1 Tidepool Company Details
11.3.2 Tidepool Business Overview
11.3.3 Tidepool Diabetes Software Introduction
11.3.4 Tidepool Revenue in Diabetes Software Business (2019-2024)
11.3.5 Tidepool Recent Developments
11.4 LifeScan, Inc (Platinum Equity)
11.4.1 LifeScan, Inc (Platinum Equity) Company Details
11.4.2 LifeScan, Inc (Platinum Equity) Business Overview
11.4.3 LifeScan, Inc (Platinum Equity) Diabetes Software Introduction
11.4.4 LifeScan, Inc (Platinum Equity) Revenue in Diabetes Software Business (2019-2024)
11.4.5 LifeScan, Inc (Platinum Equity) Recent Developments
11.5 Pharmaco Diabetes
11.5.1 Pharmaco Diabetes Company Details
11.5.2 Pharmaco Diabetes Business Overview
11.5.3 Pharmaco Diabetes Diabetes Software Introduction
11.5.4 Pharmaco Diabetes Revenue in Diabetes Software Business (2019-2024)
11.5.5 Pharmaco Diabetes Recent Developments
11.6 Ascensia Diabetes Care Holdings AG
11.6.1 Ascensia Diabetes Care Holdings AG Company Details
11.6.2 Ascensia Diabetes Care Holdings AG Business Overview
11.6.3 Ascensia Diabetes Care Holdings AG Diabetes Software Introduction
11.6.4 Ascensia Diabetes Care Holdings AG Revenue in Diabetes Software Business (2019-2024)
11.6.5 Ascensia Diabetes Care Holdings AG Recent Developments
11.7 Diabeto Medtech India Pvt. Ltd
11.7.1 Diabeto Medtech India Pvt. Ltd Company Details
11.7.2 Diabeto Medtech India Pvt. Ltd Business Overview
11.7.3 Diabeto Medtech India Pvt. Ltd Diabetes Software Introduction
11.7.4 Diabeto Medtech India Pvt. Ltd Revenue in Diabetes Software Business (2019-2024)
11.7.5 Diabeto Medtech India Pvt. Ltd Recent Developments
11.8 Abbott Diabetes Care
11.8.1 Abbott Diabetes Care Company Details
11.8.2 Abbott Diabetes Care Business Overview
11.8.3 Abbott Diabetes Care Diabetes Software Introduction
11.8.4 Abbott Diabetes Care Revenue in Diabetes Software Business (2019-2024)
11.8.5 Abbott Diabetes Care Recent Developments
11.9 Acon Diabetes Care International
11.9.1 Acon Diabetes Care International Company Details
11.9.2 Acon Diabetes Care International Business Overview
11.9.3 Acon Diabetes Care International Diabetes Software Introduction
11.9.4 Acon Diabetes Care International Revenue in Diabetes Software Business (2019-2024)
11.9.5 Acon Diabetes Care International Recent Developments
11.10 BIONIME
11.10.1 BIONIME Company Details
11.10.2 BIONIME Business Overview
11.10.3 BIONIME Diabetes Software Introduction
11.10.4 BIONIME Revenue in Diabetes Software Business (2019-2024)
11.10.5 BIONIME Recent Developments
11.11 Custo med
11.11.1 Custo med Company Details
11.11.2 Custo med Business Overview
11.11.3 Custo med Diabetes Software Introduction
11.11.4 Custo med Revenue in Diabetes Software Business (2019-2024)
11.11.5 Custo med Recent Developments
11.12 Dexcom
11.12.1 Dexcom Company Details
11.12.2 Dexcom Business Overview
11.12.3 Dexcom Diabetes Software Introduction
11.12.4 Dexcom Revenue in Diabetes Software Business (2019-2024)
11.12.5 Dexcom Recent Developments
11.13 Dottli
11.13.1 Dottli Company Details
11.13.2 Dottli Business Overview
11.13.3 Dottli Diabetes Software Introduction
11.13.4 Dottli Revenue in Diabetes Software Business (2019-2024)
11.13.5 Dottli Recent Developments
11.14 GlucoMe
11.14.1 GlucoMe Company Details
11.14.2 GlucoMe Business Overview
11.14.3 GlucoMe Diabetes Software Introduction
11.14.4 GlucoMe Revenue in Diabetes Software Business (2019-2024)
11.14.5 GlucoMe Recent Developments
11.15 MyLife
11.15.1 MyLife Company Details
11.15.2 MyLife Business Overview
11.15.3 MyLife Diabetes Software Introduction
11.15.4 MyLife Revenue in Diabetes Software Business (2019-2024)
11.15.5 MyLife Recent Developments
11.16 Nova
11.16.1 Nova Company Details
11.16.2 Nova Business Overview
11.16.3 Nova Diabetes Software Introduction
11.16.4 Nova Revenue in Diabetes Software Business (2019-2024)
11.16.5 Nova Recent Developments
11.17 Tandem Diabetes Care
11.17.1 Tandem Diabetes Care Company Details
11.17.2 Tandem Diabetes Care Business Overview
11.17.3 Tandem Diabetes Care Diabetes Software Introduction
11.17.4 Tandem Diabetes Care Revenue in Diabetes Software Business (2019-2024)
11.17.5 Tandem Diabetes Care Recent Developments
11.18 Trividia Health
11.18.1 Trividia Health Company Details
11.18.2 Trividia Health Business Overview
11.18.3 Trividia Health Diabetes Software Introduction
11.18.4 Trividia Health Revenue in Diabetes Software Business (2019-2024)
11.18.5 Trividia Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
Bionime
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health
List of Tables
    Table 1. Global Diabetes Software Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of For Smartphones
    Table 3. Key Players of For Tablet PC
    Table 4. Key Players of Web-based
    Table 5. Global Diabetes Software Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Diabetes Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Diabetes Software Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Diabetes Software Market Share by Region (2019-2024)
    Table 9. Global Diabetes Software Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Diabetes Software Market Share by Region (2025-2030)
    Table 11. Diabetes Software Market Trends
    Table 12. Diabetes Software Market Drivers
    Table 13. Diabetes Software Market Challenges
    Table 14. Diabetes Software Market Restraints
    Table 15. Global Diabetes Software Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Diabetes Software Revenue Share by Players (2019-2024)
    Table 17. Global Top Diabetes Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Software as of 2023)
    Table 18. Global Diabetes Software Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Diabetes Software Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Diabetes Software, Headquarters and Area Served
    Table 21. Global Key Players of Diabetes Software, Product and Application
    Table 22. Global Key Players of Diabetes Software, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Diabetes Software Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Diabetes Software Revenue Market Share by Type (2019-2024)
    Table 26. Global Diabetes Software Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Diabetes Software Revenue Market Share by Type (2025-2030)
    Table 28. Global Diabetes Software Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Diabetes Software Revenue Share by Application (2019-2024)
    Table 30. Global Diabetes Software Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Diabetes Software Revenue Share by Application (2025-2030)
    Table 32. North America Diabetes Software Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Diabetes Software Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Diabetes Software Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Diabetes Software Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Diabetes Software Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Diabetes Software Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Diabetes Software Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Diabetes Software Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Diabetes Software Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Diabetes Software Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Diabetes Software Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Diabetes Software Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Diabetes Software Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Diabetes Software Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Diabetes Software Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Diabetes Software Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Diabetes Software Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Diabetes Software Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Diabetes Software Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Diabetes Software Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Diabetes Software Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Diabetes Software Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Diabetes Software Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Diabetes Software Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Diabetes Software Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Diabetes Software Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Diabetes Software Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Diabetes Software Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Diabetes Software Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Diabetes Software Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Diabetes Software Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Diabetes Software Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Glooko Company Details
    Table 65. Glooko Business Overview
    Table 66. Glooko Diabetes Software Product
    Table 67. Glooko Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 68. Glooko Recent Developments
    Table 69. Accu-Chek (Roche) Company Details
    Table 70. Accu-Chek (Roche) Business Overview
    Table 71. Accu-Chek (Roche) Diabetes Software Product
    Table 72. Accu-Chek (Roche) Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 73. Accu-Chek (Roche) Recent Developments
    Table 74. Tidepool Company Details
    Table 75. Tidepool Business Overview
    Table 76. Tidepool Diabetes Software Product
    Table 77. Tidepool Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 78. Tidepool Recent Developments
    Table 79. LifeScan, Inc (Platinum Equity) Company Details
    Table 80. LifeScan, Inc (Platinum Equity) Business Overview
    Table 81. LifeScan, Inc (Platinum Equity) Diabetes Software Product
    Table 82. LifeScan, Inc (Platinum Equity) Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 83. LifeScan, Inc (Platinum Equity) Recent Developments
    Table 84. Pharmaco Diabetes Company Details
    Table 85. Pharmaco Diabetes Business Overview
    Table 86. Pharmaco Diabetes Diabetes Software Product
    Table 87. Pharmaco Diabetes Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 88. Pharmaco Diabetes Recent Developments
    Table 89. Ascensia Diabetes Care Holdings AG Company Details
    Table 90. Ascensia Diabetes Care Holdings AG Business Overview
    Table 91. Ascensia Diabetes Care Holdings AG Diabetes Software Product
    Table 92. Ascensia Diabetes Care Holdings AG Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 93. Ascensia Diabetes Care Holdings AG Recent Developments
    Table 94. Diabeto Medtech India Pvt. Ltd Company Details
    Table 95. Diabeto Medtech India Pvt. Ltd Business Overview
    Table 96. Diabeto Medtech India Pvt. Ltd Diabetes Software Product
    Table 97. Diabeto Medtech India Pvt. Ltd Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 98. Diabeto Medtech India Pvt. Ltd Recent Developments
    Table 99. Abbott Diabetes Care Company Details
    Table 100. Abbott Diabetes Care Business Overview
    Table 101. Abbott Diabetes Care Diabetes Software Product
    Table 102. Abbott Diabetes Care Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 103. Abbott Diabetes Care Recent Developments
    Table 104. Acon Diabetes Care International Company Details
    Table 105. Acon Diabetes Care International Business Overview
    Table 106. Acon Diabetes Care International Diabetes Software Product
    Table 107. Acon Diabetes Care International Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 108. Acon Diabetes Care International Recent Developments
    Table 109. BIONIME Company Details
    Table 110. BIONIME Business Overview
    Table 111. BIONIME Diabetes Software Product
    Table 112. BIONIME Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 113. BIONIME Recent Developments
    Table 114. Custo med Company Details
    Table 115. Custo med Business Overview
    Table 116. Custo med Diabetes Software Product
    Table 117. Custo med Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 118. Custo med Recent Developments
    Table 119. Dexcom Company Details
    Table 120. Dexcom Business Overview
    Table 121. Dexcom Diabetes Software Product
    Table 122. Dexcom Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 123. Dexcom Recent Developments
    Table 124. Dottli Company Details
    Table 125. Dottli Business Overview
    Table 126. Dottli Diabetes Software Product
    Table 127. Dottli Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 128. Dottli Recent Developments
    Table 129. GlucoMe Company Details
    Table 130. GlucoMe Business Overview
    Table 131. GlucoMe Diabetes Software Product
    Table 132. GlucoMe Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 133. GlucoMe Recent Developments
    Table 134. MyLife Company Details
    Table 135. MyLife Business Overview
    Table 136. MyLife Diabetes Software Product
    Table 137. MyLife Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 138. MyLife Recent Developments
    Table 139. Nova Company Details
    Table 140. Nova Business Overview
    Table 141. Nova Diabetes Software Product
    Table 142. Nova Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 143. Nova Recent Developments
    Table 144. Tandem Diabetes Care Company Details
    Table 145. Tandem Diabetes Care Business Overview
    Table 146. Tandem Diabetes Care Diabetes Software Product
    Table 147. Tandem Diabetes Care Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 148. Tandem Diabetes Care Recent Developments
    Table 149. Trividia Health Company Details
    Table 150. Trividia Health Business Overview
    Table 151. Trividia Health Diabetes Software Product
    Table 152. Trividia Health Revenue in Diabetes Software Business (2019-2024) & (US$ Million)
    Table 153. Trividia Health Recent Developments
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Diabetes Software Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Diabetes Software Market Share by Type: 2023 VS 2030
    Figure 3. For Smartphones Features
    Figure 4. For Tablet PC Features
    Figure 5. Web-based Features
    Figure 6. Global Diabetes Software Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Diabetes Software Market Share by Application: 2023 VS 2030
    Figure 8. Type 1 Diabetes Case Studies
    Figure 9. Type 2 Diabetes Case Studies
    Figure 10. Diabetes Software Report Years Considered
    Figure 11. Global Diabetes Software Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Diabetes Software Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Diabetes Software Market Share by Region: 2023 VS 2030
    Figure 14. Global Diabetes Software Market Share by Players in 2023
    Figure 15. Global Top Diabetes Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Software as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Diabetes Software Revenue in 2023
    Figure 17. North America Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Diabetes Software Market Share by Type (2019-2030)
    Figure 19. North America Diabetes Software Market Share by Application (2019-2030)
    Figure 20. North America Diabetes Software Market Share by Country (2019-2030)
    Figure 21. United States Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Diabetes Software Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Diabetes Software Market Share by Type (2019-2030)
    Figure 25. Europe Diabetes Software Market Share by Application (2019-2030)
    Figure 26. Europe Diabetes Software Market Share by Country (2019-2030)
    Figure 27. Germany Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Diabetes Software Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Diabetes Software Market Share by Type (2019-2030)
    Figure 35. China Diabetes Software Market Share by Application (2019-2030)
    Figure 36. Asia Diabetes Software Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Diabetes Software Market Share by Type (2019-2030)
    Figure 38. Asia Diabetes Software Market Share by Application (2019-2030)
    Figure 39. Asia Diabetes Software Market Share by Region (2019-2030)
    Figure 40. Japan Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Diabetes Software Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Diabetes Software Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Diabetes Software Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Diabetes Software Market Share by Country (2019-2030)
    Figure 50. Brazil Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Diabetes Software Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Glooko Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 57. Accu-Chek (Roche) Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 58. Tidepool Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 59. LifeScan, Inc (Platinum Equity) Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 60. Pharmaco Diabetes Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 61. Ascensia Diabetes Care Holdings AG Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 62. Diabeto Medtech India Pvt. Ltd Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 63. Abbott Diabetes Care Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 64. Acon Diabetes Care International Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 65. BIONIME Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 66. Custo med Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 67. Dexcom Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 68. Dottli Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 69. GlucoMe Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 70. MyLife Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 71. Nova Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 72. Tandem Diabetes Care Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 73. Trividia Health Revenue Growth Rate in Diabetes Software Business (2019-2024)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Marketplace Apps Software Market Insights Forecast to 2030
Global Diabetes Therapeutics and Diagnostics Market Insights Forecast to 2030
Global Diabetic Tests Market Insights Forecast to 2030
Global Prescription Writing Software Market Insights Forecast to 2030
Global Patient Intake Software Market Insights Forecast to 2030
Global Home Health Software Market Insights Forecast to 2030
Global Metabolic Disorder Therapeutics Market Insights Forecast to 2030
Business Analytics Software Market
Global Practice Analytics Software Market Insights Forecast to 2030
Global Chronic Care Management Software Market Insights Forecast to 2030
Global Spreadsheets Software Market Insights Forecast to 2030
Global Trading Software Market Insights Forecast to 2030
Global Marketing Analytics Tools and Software Market Insights Forecast to 2030
Global Patient Management Software and Services Market Insights Forecast to 2030
Global Pricing Software Tools Market Insights Forecast to 2030
Global Risk Assessment Software Market Insights Forecast to 2030
Global Price Comparison Software Market Insights Forecast to 2030
Global Calorie Counter Software Market Insights Forecast to 2030
Global Gambling Software Market Insights Forecast to 2030
Global Food Manufacturing Software Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions